Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$17.66 - $28.92 $1.06 Million - $1.73 Million
-59,930 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$23.25 - $37.73 $1.39 Million - $2.26 Million
59,930 New
59,930 $1.47 Million

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $114M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Trustees Of Columbia University In The City Of New York Portfolio

Follow Trustees Of Columbia University In The City Of New York and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustees Of Columbia University In The City Of New York, based on Form 13F filings with the SEC.

News

Stay updated on Trustees Of Columbia University In The City Of New York with notifications on news.